RightFit
RecruitingPhase not listed

Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery

Potential Impact of the COVID -19 Pandemic on Financial Toxicity in Breast Cancer Surgical Patients: The Impact on Out of Pocket Costs, Lost Wages and Economic Strain

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years and older
Sex
Female only
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Time periods mentioned: 1 year
  • Procedures mentioned: Questionnaires

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "Assess if financial toxicity or distress is associated with worse BREAST-questionnaire (Q) performance as well as quality of life."
  • "OUTLINE: Patients complete up to 4 electronic questionnaires over 15 minutes before surgery and at 6, 12, and 24 months after surgery."
  • "After completion of study, patients will be followed up for 1 year."
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study looks at how the COVID-19 pandemic affects patient costs, lost pay, and job loss during breast surgery, with or without breast rebuilding. It is for people who need breast surgery to treat cancer or prevent it because of gene changes or a strong family history.

This study investigates the impact of COVID-19 pandemic on out-of-pocket costs, lost wages, and unemployment in patients with breast cancer undergoing breast surgery. Post-mastectomy reconstructive patients are at high risk for financial toxicity (adverse effects of escalating health care cost on well-being). The goal of this study is to collect information about financial costs patients may have as a result of surgical treatment for cancer with or without breast reconstruction and to learn if COVID-19 affects patient costs of breast reconstruction. This may help researchers demonstrate the financial consequences of undergoing breast surgery.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Need surgery for invasive breast cancer (cancer that has grown into nearby breast tissue) or DCIS (cancer inside the milk ducts), or to prevent cancer because of gene changes or a strong family history.
  • Speak English.
  • Can give consent to join the study.
  • Can fill out surveys on a computer.

Who can't join

  • Do not speak English.
  • Have cancer that has come back, spread to distant parts of the body, or another separate cancer at the same time.
  • Are getting treatment that removes the cancer but keeps most of the breast.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * Have an indication for surgical treatment of invasive breast cancer or ductal breast carcinoma in situ (DCIS) or prophylaxis in the setting of genetic mutations or strong family history * English-speaking * Able to complete consent * Able to fill out computer survey material Exclusion Criteria: * Non-English-speaking * Those with recurrent or metastatic disease or concurrent primary cancers * Patients undergoing breast conservation therapy will also be excluded from the study

Study sites (4)

TX